---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088428"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:44:07.654221+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ApolloMed Q2 revenue $348.2M (+29% YoY); adj. EBITDA $35.8M (+44%); reaffirms FY23 guidance

## Summary
- Revenue $348.2M (+29% YoY); Care Partners revenue $325.2M (+32%); net income $13.2M (+10%).
- Adjusted EBITDA $35.8M (+44% YoY); reaffirms FY23 guidance: revenue $1.3-1.5B, Adj. EBITDA $120-160M.
- Recent deals: entered agreement to acquire Texas Independent Providers (120+ PCPs); formed partnership with IntraCare (425+ providers) with $25M convertible note.
- Tax restatement for 2020-2022 related to intercompany dividends; no impact on revenue, EBITDA, or past/forward periods.
- Cash and investments $297.7M; total stockholders' equity $566M.

## SEC filing metadata
- accession: 0001104659-23-088428
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465923088428/0001104659-23-088428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465923088428/tm2323017d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088428
- JSON: https://secwatch.observer/filing/0001104659-23-088428.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088428.txt

## Key facts
- Earnings Releases
  Astrana Health, Inc. reported three and six months ended June 30, 2023 results: revenue $348.2 million, net income $13.2 million. Guidance reaffirmed.
  - Period: three and six months ended June 30, 2023
  - Revenue: $348.2 million
  - Net income: $13.2 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: full-year 2023.” Financial Highlights for Second Quarter Ended June 30, 2023: All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Total revenue of $348.2 million, up 29% from $269.7 million • Care Partners revenue of $325.2 million, up 32% from $247.3 million • Net income attributable to ApolloMed of $13.2 million, up 10% from $12.0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465923088428/0001104659-23-088428-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.